New Medicines, Novel Insights: Advancing rare disease drug development

Novel therapies for rare diseases offer hope for thousands of patients and their families. This interactive report presents insights from Parexel experts doing everything humanly possible to deliver on the promise of patient-focused drug development – and to bring more rare disease treatments to market, faster.

Explore the report

 

Return to Insights Center

Related Insights

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Blog

Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression

Apr 23, 2024

Blog

Celebrating 40 Years of Rare Disease Progress: WODC Highlights

Jun 6, 2023

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Blog

Accelerating Delivery and Patient Access to Rare Disease Treatments – Highlights from World Orphan Drug Congress

May 2, 2024

Report

New Medicines, Novel Insights: Achieving patient-guided drug development

Oct 30, 2023

Blog

A patient-centric approach to managing clinical trial complexity

Jul 13, 2021

Article

Decentralized trial tools and technologies are here to stay: A regulatory perspective

Jul 23, 2021

Podcast

Why Rare Disease Therapeutics Need Early Market Access Planning

Jan 4, 2023

Article

Three ways to work with the FDA for better patient-focused trials

Jul 29, 2021

Whitepaper

The Chinese Pharmaceutical Market: Size, R&D, Regulations, Market Access and Innovations

Mar 9, 2023

Article

Part 1 - Preparing for a Risk-Based Future: What ICH Revisions Mean for Clinical Trial Design and Conduct

Sep 14, 2021